Artificial Intelligence3 years ago
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™
Therapixel announced today that MammoScreen™ has successfully obtained the CE mark. After having received FDA clearance for commercial sales in the United States in March 2020, this AI solution...